• In recent weeks, law firm Bronstein, Gewirtz & Grossman, LLC announced an investigation into Medical Properties Trust after the REIT disclosed a default by its third-largest tenant, Healthcare Systems of America, which represents about 8% of its total assets and is currently involved in competing lawsuits.
• This combination of a major tenant default and legal scrutiny raises fresh questions about Medical Properties Trust’s tenant quality, asset risk, and overall resilience.
• We’ll now examine how the Healthcare Systems of America default and resulting legal investigation could reshape Medical Properties Trust’s investment narrative.

This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.

Medical Properties Trust Investment Narrative Recap

To own Medical Properties Trust, you need to believe its hospital-focused portfolio can produce reliable rent even as some operators struggle. Right now, the key near term catalyst is stabilizing rent collections from re-tenanting efforts, while the biggest risk is tenant credit quality and related asset impairments. The Healthcare Systems of America default appears directly tied to this risk and could meaningfully influence how confident investors feel about future cash flow and dividend support.

Against this backdrop, the most relevant recent development is the February 2026 earnings report, which showed a return to positive quarterly net income alongside ongoing full year losses. That mix of improving results and lingering red ink already had investors focused on whether MPT can rebuild earnings quality. The new default and legal investigation now sit on top of that picture, potentially affecting how durable any earnings recovery really is.

Yet beneath the headline investigation, the concentration of rent with financially stressed tenants is something investors should be aware of, because it may...

Medical Properties Trust's narrative projects $1.1 billion revenue and $136.7 million earnings by 2028. This requires 3.1% yearly revenue growth and an earnings increase of roughly $1.5 billion from -$1.4 billion today.

Uncover how Medical Properties Trust's forecasts yield a $5.17 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Before this news, the most optimistic analysts were projecting earnings of about US$164.7 million by 2029, but that more upbeat story around tenant stress and rent stability could look very different once this latest default is fully reflected.

Explore 4 other fair value estimates on Medical Properties Trust - why the stock might be worth just $5.17!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Medical Properties Trust research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Medical Properties Trust research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Medical Properties Trust's overall financial health at a glance.

No Opportunity In Medical Properties Trust?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

• We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• Capitalize on the AI infrastructure supercycle with our selection of the 36 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Uncover the next big thing with 31 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.